Delving Into Participation Trends of Scleroderma Clinical Trials

Deciphering Patient Participation: Insights From Observational Data in Scleroderma Clinical Trials

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06264492

Enrollment

500

Registered

2024-02-20

Start date

2025-03-31

Completion date

2027-03-31

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma

Keywords

scleroderma

Brief summary

Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics. The study will analyze data from diverse demographic viewpoints to uncover recurring trends that could provide valuable insights for future patients with scleroderma.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient has been diagnosed with scleroderma * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older

Exclusion criteria

* Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Design outcomes

Primary

Measure	Time frame
Rate of patients in clinical research for scleroderma	3 months
Number of scleroderma study participants who stay committed until clinical study wraps up	12 months

Countries

United States

Contacts

Primary ContactMichael B Gill

bask@withpower.com4159004227

Outcome results